NASDAQ:10x Genomics, Inc.

График котировок 10x Genomics, Inc.

Добавить в список сравнения Добавить в список сравнения
Добавить в список отслеживания Добавить в список отслеживания
Добавить в портфель Добавить в портфель

Основные параметры

P/S 52.84
P/BV 18.33
EV/EBITDA -126.39
EBITDA -0.06
Цена ао 167.5

Инсайдерская торговля

Дата сделки Дата раскрытия Инсайдер Тип Цена Объем Количество Доля до, % Доля после, % Документ
23.12.2020 28.12.2020 McAnear Justin J.
Chief Financial Officer
Покупка 5.04 99 999.00 19841 0 0.1 ссылка
24.12.2020 28.12.2020 Hindson Benjamin J.
See Remarks
Покупка 1.12 41 032.00 36636 0 0.19 ссылка

Основные владельцы

Institutions Объем Доля, %
First Trust Portfolios L.P. 48116 0.07
Pzena Investment Management Inc 137932 0.2
Brandywine Global Investment Mgmt, LLC 57027 0.08
Guggenheim Funds Distributors, LLC 25 0
PPM America, Inc. 418900 0.6
Invesco Capital Markets Inc 30 0
ID-Sparinvest, Filial af Sparinvest S.A., Luxembourg 527007 0.76
Fuller & Thaler Asset Mgmt 10209921 14.73
Invesco Capital Management LLC 196190 0.28
Jackson National Asset Management LLC 914729 1.32
Hennion & Walsh, Inc 200 0
Sparinvest S.A. 198949 0.29
Pacific Life Fund Advisors LLC (PLFA) 202709 0.29
Security Investors, LLC 34175 0.05
Sabrient Systems 10646 0.02
UBS Asset Management (Americas) Inc 164258 0.24
Fisher Investments CA 77036 0.11
TCW Investment Management Co LLC 83636 0.12
Federated Hermes, Inc. 101921 0.15
Nationwide Fund Advisors 213474 0.31

Содержится в ETF

ETF Доля, % Доходность за год, %
Vanguard Small Cap Value ETF 0.45 13.19
Schwab U.S. Small-Cap ETF 0.31 28.09
Principal Healthcare Innovators Index ETF 1.36 55.27
US Global GO GOLD and Precious Metal Miners ETF 3.87 22.35
Renaissance IPO ETF 2.36 111.77
Entrepreneur 30 Fund 3.01 53.60
AI Powered International Equity ETF 1.47 19.23
Sprott Gold Miners ETF 3.33 25.45
Sprott Junior Gold Miners ETF 3.27 50.01

Похожие компании

Описание 10x Genomics, Inc.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. Its company offers chromium instruments, enzymes, microfluidic chips, slides, reagents, and other consumable products. The company's single cell solution runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell ATAC for measuring epigenetics, including the physical organization of DNA; single cell CNV for measuring cellular heterogeneity through DNA changes, such as copy number variation; and visium spatial gene expression solution that measures the spatial gene expression patterns across a tissue sample. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10X Genomics, Inc. in November 2014. 10x Genomics, Inc. was founded in 2012 and is headquartered in Pleasanton, California.